Abstract:Objective: To explore the effects of Metadoxine treatment in patients with acute alcoholism. Methods: A total of 104 patients with acute alcoholism admitted to the emergency department of our hospital from January 2020 to December 2022 were selected as the study subjects, and were randomly divided into the conventional group (n=52) and the Metadoxine group (n=52) by using the method of randomized numerical table. The control group was given conventional treatment, and the observation group was given Metadoxine on the basis of conventional treatment. Clinical indexes (awakening time, symptom disappearance time) were recorded in the two groups, blood gas indexes [blood oxygen saturation (SaO2), partial pressure of oxygen (PO2)] and breath alcohol concentration (BrAC) levels were compared between the two groups before and after treatment, oxidative stress [superoxide dismutase (SOD)] status was compared between the two groups before and after treatment, and liver and kidney function [alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood creatinine (Scr), urea nitrogen (BUN)], and coagulation function [prothrombin time (PT), prothrombin time (TT), activated partial thromboplastin time (APTT), fibrinogen (FIB)]. Results: The awakening time and symptom disappearance time of the Metadoxine group were shorter than that of the conventional group (P all <0.05); after treatment, the levels of SaO2, PO2, SOD and FIB of the two groups increased compared with those before treatment, and the level of change of Metadoxine was higher than that of the conventional group (P all <0.05); the levels of BrAC, liver and renal function indexes (ALT, AST, Scr, BUN), and some of the indicators of coagulation function (PT, TT, APTT) levels were lower than before treatment, and the level of change of Metadoxine was higher than that of the conventional group (all P<0.05). Conclusion: Metadoxine can shorten the awakening time and symptom disappearance time of patients with acute alcohol intoxication, improve the blood gas status of patients, alleviate the oxidative stress reaction of patients, and improve the liver and kidney function and coagulation function of patients.
王小银, 左爽, 徐礼友, 李海山. 美他多辛治疗对急性酒精中毒患者苏醒时间症状消失时间和氧化应激反应的影响[J]. 河北医学, 2024, 30(1): 163-168.
WANG Xiaoyin, ZUO Shuang, XU Liyou, et al. Effect of Metadoxine Treatment on Time to Awakening Time to Symptom Disappearance and Oxidative Stress in Patients with Acute Alcohol Intoxication. HeBei Med, 2024, 30(1): 163-168.
[1] 狄才英,连美英,李东旭.院前气管插管术治疗急性酒精中毒合并呼吸衰竭患者的临床效果[J].广西医学,2021,43(2):175-178. [2] 周菁,田丽晓,张丽娜.醒脑静注射液联合盐酸纳美芬对急性重度酒精中毒患者氧化应激反应及神经递质水平的影响[J].世界临床药物,2022,43(11):1470-1474. [3] Caputo F,Testino G.Orthotopic liver transplantation for patients with end-stage alcohol-related liver disease and severe acute alcohol-related hepatitis[J].Minerva Surg,2021,76(5):444-449. [4] 陆丽,赵磊,张德桂,等.双管喉罩在急性重度酒精中毒患者呼吸道管理中的应用价值[J].安徽医学,2020,41(8):957-959. [5] Suresh Babu K,Paradesi D.Investigation of related impurities in metadoxine by a reversed phase high performance liquid chromatography technique[J].Anal Sci,2021,37(4):581-584. [6] Sinenchenko AG,Lodyagin AN,Savello VE,et al.Acute severe oral poisoning with 1,4-butandiol and ethanol with the development of coma[J].Zh Nevrol Psikhiatr Im S S Korsakova,2020,120(3):77-81. [7] Mirijello A,Addolorato G.Treatment of acute alcohol intoxication:The role of metadoxine[J].Eur Intern Med,2023,110(1):128. [8] 颜建辉,何鹤彬,王敏.纳洛酮联合舒血宁对急性乙醇中毒患者SODGSHiNOS的影响[J].河北医学,2020(6):936-940. [9] 马君媛.酒毒内蕴型急性酒精中毒患者应用醒脑静治疗对呼气酒精浓度水平的影响[J].四川中医,2020,38(8):111-114. [10] 孙红菊,王衍颜,徐丛聪,等.硫普罗宁联合美他多辛治疗酒精性肝病患者疗效初步研究[J].实用肝脏病杂志,2020,23(1):54-57. [11] 蒋雯,韦亦霖,温清,等.美他多辛通过抑制巨噬细胞和中性粒细胞向肝脏浸润缓解急性酒精性肝损伤[J].中国药学(英文版),2022,31(1):47-54. [12] 黄帅,陈文玲.美他多辛联合硫普罗宁对于酒精性肝病肝纤维化及肝功能的影响[J].中国医刊,2020,55(3):263-268.